Chambrelan, E.
8  results:
Search for persons X
?
1

Durées de traitement et post-traitement des traitements sys..:

Chambrelan, E. ; Barbarot, S. ; Bekel, L....
Annales de Dermatologie et de Vénéréologie.  147 (2020)  12 - p. A97 , 2020
 
?
2

Drug survival and postdrug survival of systemic treatments ..:

Chambrelan, E. ; Barbarot, S. ; Bekel, L....
British Journal of Dermatology.  183 (2020)  2 - p. 376-378 , 2020
 
?
3

Survenue d'une dermatose à IgA linéaire sous pembrolizumab:

Chambrelan, E. ; Kerneuzet, I. ; Le Gall, F...
Annales de Dermatologie et de Vénéréologie.  146 (2019)  12 - p. A154-A155 , 2019
 
?
4

Drug survival and post-drug survival of systemic treatments..:

Chambrelan, E ; Barbarot, S ; Bekel, L...
info:eu-repo/semantics/altIdentifier/doi/10.1111/bjd.18941.  , 2020
 
?
5

Drug survival and post-drug survival of systemic treatments..:

Chambrelan, E ; Barbarot, S ; Bekel, L...
info:eu-repo/semantics/altIdentifier/doi/10.1111/bjd.18941.  , 2020
 
?
6

Drug survival and post-drug survival of systemic treatments..:

Chambrelan, E ; Barbarot, S ; Bekel, L...
info:eu-repo/semantics/altIdentifier/doi/10.1111/bjd.18941.  , 2020
 
?
7

Drug survival and post-drug survival of systemic treatments..:

Chambrelan, E ; Barbarot, S ; Bekel, L...
info:eu-repo/semantics/altIdentifier/doi/10.1111/bjd.18941.  , 2020
 
?
8

Drug survival and post-drug survival of systemic treatments..:

Chambrelan, E ; Barbarot, S ; Bekel, L...
info:eu-repo/semantics/altIdentifier/doi/10.1111/bjd.18941.  , 2020
 
1-8